Combined synopsis and solicitation
Custom Monoclonal Antibodies
75D30124Q78028
Centers for Disease Control and Prevention, CDC Office of Acquisition Services. Research and Development in Biotechnology (except Nanobiotechnology).
Awarded
$0.00 obligated so far on USAspending
Description
As published on SAM.gov.
GenScript Custom Monoclonal Antibodies This contract action is for supplies that the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals. CEMB utilizes GenScript Custom Monoclonal Antibodies within our laboratory. The supply of Custom Monoclonal antibodies is paramount to our lab work.
This notice of intent is not a request for competitive quotations; however, all quotations/responses received within fifteen (15) days of the issuance of this notice will be considered by the government. The NAICS 541714 and the PSC AJ13 are the classifications for this biological procurement. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government.
Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to Gary Morgan, Contract Specialist at gmorgan1@cdc.gov by 5:00PM EST Monday, July 29, 2024.
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- Recipient
- Genscript USA Inc.
- UEI
- KVLBRRAQ6UX1
- CAGE
- 5THB5
- Vendor location
- Piscataway, NJ
- Contract
- 75D30124P19829, purchase order
- Obligated
- $0.00
- Actions
- 3 between September 5, 2024 and September 30, 2025
- Competition
- Not Competed, 1 offer received
- Set-aside reported
- No Set Aside Used.
- Described as
- Custom Monoclonal Antibodies
- Match
- solicitation number 75D30124Q78028 equals the FPDS solicitation identifier; same awarding office 75D301 (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
July 22, 2024
Combined synopsis and solicitation
Due July 29, 2024 at 5:00 PM EDT. SAM.gov, notice 7c44cf9d0dfd4804bf9d420fbc335c89
Points of contact
- Gary Morganglm5@cdc.gov7704882639
Also open from this buyer
- (Presolicitation Notice) Intent to Sole Source - Grants Management TrainingPresolicitationNAICS 611430Atlanta, GAPR00251Closes todaySep 17
- (Presolicitation Notice) Intent to Sole Source - Biol Specimens for Lenacapavir PEPPresolicitationNAICS 621511Atlanta, GAPR97866Closes todaySep 17
- Facilitating Research, Programmatic, and Operational Support of the National Amyotrophic Lateral Sclerosis’ (ALS) Biorepository in support of the ALS Registry ActCombined synopsis and solicitationSmall businessNAICS 621991Georgia75D301-Q-26-95343Closes todaySep 17
- The National ALS Registry Expansion of Outreach and Awareness to Persons with ALS in Select States Covered by the Amyotrophic Lateral Sclerosis (ALS) AssociationPresolicitationNAICS 813212Atlanta, GA2026-ALSACloses todaySep 17
- Installation, Configuration, Software Upgrade, Preventive Maintenance, and Repair Services for the Government-Owned Sci-Print VXL/VXQ Automated Tube Labeling SystemSolicitationNAICS 334516Atlanta, GA75D30126Q79281Closes todaySep 17